Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2005-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Changes in the Mineral Metabolism After a High Phosphorous Containing Meal in Dialysis Patients
NCT03868371
Vitamin B12 Status and Its Impact on Chronic Haemodialysis Patient
NCT06441721
The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density
NCT07171216
Underlying Causes of Low Vitamin K Status in Hemodialysis Patients
NCT03493087
The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status
NCT02046746
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CKD
Elevated se-creatinine + proteinuria
No interventions assigned to this group
Healthy controls
Healthy controls, normal se-creatinine, no proteinuria
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elevated serum creatinine
* Proteinuria
* Informed and written consent
Control subjects:
* Normal serum creatinine and creatinine clearance
* No proteinuria
Exclusion Criteria
* Renal replacement therapy (dialysis)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Aarhus University Hospital
OTHER
Aalborg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Henrik Birn
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henrik Birn, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Nephrology, Aalborg Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nephrology, Aalborg Hospital
Aalborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VN 2005/44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.